V-ATPase Dysfunction in the Brain: Genetic Insights and Therapeutic Opportunities

Area of Science:

• Cell Biology
• Neuroscience
• Genetics

Background:

• Vacuolar-type ATPase (v-ATPase) is crucial for cellular acidification and lysosomal function.
• Neurons are particularly vulnerable to lysosomal dyshomeostasis due to their unique biology.
• v-ATPase impairment is linked to neuronal dysfunction and neurodegeneration.

Purpose of the Study:

• To review genetic and functional evidence connecting v-ATPase subunits and accessory proteins to brain disorders.
• To highlight emerging therapeutic strategies for v-ATPase-associated lysosomal defects.

Main Methods:

• Literature review of genetic and functional studies.
• Analysis of animal models and human genetic diseases.
• Synthesis of current therapeutic approaches.

Main Results:

• Alterations in v-ATPase genes cause impaired brain development and synaptic function.
• v-ATPase dysfunction underlies various human brain disorders, including encephalopathies, epilepsy, and neurodegenerative diseases.
• Emerging therapies target lysosomal defects in v-ATPase dysfunction.

Conclusions:

• v-ATPase is a critical regulator of neuronal health, and its dysfunction is implicated in a spectrum of brain disorders.
• Targeting v-ATPase-related lysosomal defects offers potential therapeutic avenues for neurological conditions.